Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.
about
Genetic-background modulation of core and variable autistic-like symptoms in Fmr1 knock-out mice.Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses.Altered Neuronal and Circuit Excitability in Fragile X Syndrome.Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum DisordersLearning and behavioral deficits associated with the absence of the fragile X mental retardation protein: what a fly and mouse model can teach us.Cortical HCN channels: function, trafficking and plasticityRegulatory BC1 RNA and the fragile X mental retardation protein: convergent functionality in brainIon channels in genetic and acquired forms of epilepsy.Fragile X syndrome: A review of clinical managementThe fragile X gene and its functionGenetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.Etiology of a genetically complex seizure disorder in Celf4 mutant miceNeuronal BC RNAs cooperate with eIF4B to mediate activity-dependent translational controlSensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models.Electrocortical changes associated with minocycline treatment in fragile X syndrome.Stem cells and modeling of autism spectrum disorders.From FMRP function to potential therapies for fragile X syndrome.Modeling fragile X syndrome in the Fmr1 knockout mouseAuditory processing in fragile x syndrome.Soy-based diet exacerbates seizures in mouse models of neurological diseaseResilience to audiogenic seizures is associated with p-ERK1/2 dephosphorylation in the subiculum of Fmr1 knockout mice.Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS).R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures.The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamideCGG repeat in the FMR1 gene: size mattersMultiple autism-like behaviors in a novel transgenic mouse model.Alzheimer's disease and Down syndrome rodent models exhibit audiogenic seizures.Wild-type male offspring of fmr-1+/- mothers exhibit characteristics of the fragile X phenotypeSeizure susceptibility and mortality in mice that over-express amyloid precursor proteinCellular plasticity for group I mGluR-mediated epileptogenesis.Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.BC1 regulation of metabotropic glutamate receptor-mediated neuronal excitability.Circuit level defects in the developing neocortex of Fragile X mice.Biallelic mutations in the gene encoding eEF1A2 cause seizures and sudden death in F0 miceAcamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxietyThe cyclic AMP cascade is altered in the fragile X nervous systemLithium: a promising treatment for fragile X syndrome.Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and AutismFMR1 gene and fragile X syndrome.
P2860
Q21135541-A39A09AA-0227-4D4C-BD46-2C8C12048C8FQ24610600-3BC51629-B1E4-40E0-938E-D851B360836BQ26796317-3795A00B-B346-48E5-8BF9-CB4D7B287561Q26796321-7A2A3CBD-0912-4A4F-B80F-B47E94406CEBQ26866506-569AD121-633B-4AC7-9B53-6B350CD01616Q27027165-72E629D0-60BE-4864-8149-50B258430521Q27312243-346926F2-DCE5-40B7-A0AC-F6D39D9D72B8Q27693827-C176A452-7935-4C6A-B1B2-52EE7DEE4227Q28076950-DE2B3673-E0EE-422E-89D5-5DCB4CA0FB0AQ28201533-CC09A040-3B88-4464-B604-D98763258586Q28261563-88F76701-641A-48D2-BCC5-EAF760CD0CFCQ28508321-321F55E6-8217-43A7-AA15-D453837934BCQ28570179-1353B564-CBD0-4468-AC81-B7E34CA41945Q30354621-9E70E8DA-9EDA-4450-A4EF-BF01965AD42AQ30378165-83B7DE30-C000-4FF4-9602-8A85F57FBCDCQ30401824-BE3BC272-342A-494F-9446-549E1CEBCB3EQ30410502-3D15A8C8-AF96-4212-A025-2E9C38E5AC97Q30420595-BB38877C-7E7D-4BF5-90EE-B3462CFE997AQ30442883-37CBB02E-19D0-4C91-9577-8C6A9EF12468Q30445118-96526B4D-EB59-4D6C-BB1C-21A09C96101CQ30455160-791E1682-164F-4340-B605-D668216F3426Q30457688-DAF70F69-C80B-47DA-B6CD-AE20FDC4AB24Q30461090-CDBD9B71-4C07-4E00-8D0B-D82814CB4432Q30462810-B755002A-19AF-4D1F-9628-F1BFC8A4B74DQ30464036-A82F87E1-5047-4330-B416-D3F343F70D76Q30469511-9C5BEF7D-9BA6-492D-BAFC-9EE5F527C9AEQ30477832-636AA60C-B05D-439B-AA51-DE157F05CC36Q30480496-AFF41200-4EE5-4611-9067-086201AE13D4Q30482779-2E4EE4FB-5744-4261-B9BD-3B68B22E9BE1Q30488024-769DA8A6-0F5B-4786-938A-F6E3AE93A1EAQ30488395-657C8327-EA4C-4C61-8963-2D7D1440EF5CQ30488610-EC7694FD-039E-47B2-B497-A7B16AE0FDB2Q30494390-81443410-DF1D-4F93-A3A4-1F34D663CA80Q30540967-F27C17D3-2A67-42D6-B327-8863615D5A7BQ30844107-991A90C3-023D-4F39-A7B7-A65B286AD021Q30855390-F9C53735-3334-4A78-8971-50C4B34B3A3CQ33300336-67D42793-3937-487A-A323-30B5F7CE6934Q33777951-A4DA0891-DD33-4B7C-8EEF-0C33FBFFED90Q33877423-BB21C0CD-6C02-4C46-ADDA-4E2AEC7EB175Q34141674-3D2718BA-2464-413F-8B50-94C4B5752237
P2860
Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.
@en
Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.
@nl
type
label
Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.
@en
Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.
@nl
prefLabel
Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.
@en
Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.
@nl
P2093
P2860
P1433
P1476
Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome.
@en
P2093
Calabrese G
De Sarro GB
Musumeci SA
P2860
P356
10.1111/J.1528-1157.2000.TB01499.X
P577
2000-01-01T00:00:00Z